5 results
10-K/A
2022 FY
Zymeworks Inc.
28 Apr 23
Annual report (amended)
4:15pm
, and by and Jeremy C. Green as the principal of Redmile. The address for this entity and individual is One Letterman Drive Building D, Suite D3-300, San Francisco, CA
DEF 14A
Zymeworks Inc.
25 Nov 22
Definitive proxy
6:16am
accounts and Jeremy C. Green as of October 13, 2022. The address for this entity and individual is One Letterman Drive Building D, Suite D3-300, San
424B3
Zymeworks Inc.
2 Sep 22
Prospectus supplement
4:06pm
shares held by Redmile Group, LLC, Jeremy C. Green and Redmile Biopharma Investments III, L.P. as of August 5, 2022. The address for these entities
S-4/A
Zymeworks Inc.
19 Aug 22
Registration of securities issued in business combination transactions (amended)
4:47pm
and company records, consists of 5,758,241 common shares held by Redmile Group, LLC, Jeremy C. Green and Redmile Biopharma Investments III, L.P
- Prev
- 1
- Next